Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

Best Peptides for Healing

Best Peptides for Healing

The most effective peptides for injury recovery, tissue repair, and accelerating healing, ranked by evidence, versatility, and real-world results.

Expert Protocols

Reviewed protocols from researchers, physicians, and creators who have publicly disclosed their dosing.

Ranked list

1

BPC-157

Healing & RecoveryHalf-life: 15.2 min IV in rats, 5.3 min in dogs; under 30 min after IM; no human data250 mcg-500 mcg
Community Consensus

The single most popular healing peptide. In animal studies, BPC-157 promotes angiogenesis, speeds tendon and ligament repair, and heals gut lining. Its ability to be injected locally near injuries or taken orally for gut healing makes it uniquely versatile.

Pros
  • Works locally and systemically
  • Heals gut injuries when given orally to rats
  • No serious adverse events reported in five small human studies, though FDA calls their safety monitoring unclear (July 2026)
  • Pairs with nearly every other peptide
Cons
  • Mostly animal data: five small human studies (FDA, July 2026), none a controlled injury trial
  • Short half-life requires daily dosing
2

TB-500

Healing & RecoveryHalf-life: ~5 hours (estimated, never measured in humans)2 mg-5 mg
Community Consensus

The systemic healing complement to BPC-157. TB-500 promotes cell migration, reduces inflammation, and upregulates actin for tissue repair. Unlike BPC-157, it works regardless of injection site.

Pros
  • Fully systemic: injection site doesn't matter
  • Reduces inflammation and fibrosis
  • Dosed less often than BPC-157 (community reports; no human half-life measured)
  • Most popular pairing with BPC-157
Cons
  • More expensive than BPC-157
  • Loading phase required for best results
3

GHK-Cu

Anti-AgingHalf-life: ~1 hour1 mg-3 mg
Community Consensus

A copper peptide that raises or lowers the activity of at least 4,000 human genes in cell-line data (PMID 26236730). GHK-Cu stimulates collagen production, promotes wound healing, and has both injectable and topical applications for skin-level healing.

Pros
  • Available as injectable and topical
  • Stimulates collagen and elastin
  • Anti-aging and healing in one
  • Well-studied gene expression data
Cons
  • Short half-life (~1 hour, estimated; no human PK study)
  • Avoid if copper sensitivity exists
4

KPV

ImmuneHalf-life: ~30 min plasma (functional anti-inflammatory activity persists 4-6 hours)200 mcg-1 mg
Speculative

A potent anti-inflammatory tripeptide that specifically targets the inflammatory component of healing. KPV is especially useful for gut inflammation and chronic injuries where inflammation is the main barrier to recovery.

Pros
  • Powerful anti-inflammatory without immunosuppression
  • Can be taken orally for gut healing
  • Only 3 amino acids, simple and well-tolerated
  • Complements BPC-157 and TB-500
Cons
  • Limited standalone research
  • Best used as part of a stack rather than alone
5

Thymosin Beta-4

Healing & RecoveryHalf-life: ~2 hours (IV)750 mcg-3 mg
Community Consensus

The full-length 43-amino-acid parent protein of TB-500. Thymosin Beta-4 retains all of TB-500's healing properties plus an extra Ac-SDKP domain that provides cardioprotective and anti-fibrotic effects not found in the fragment. It has the most human trial data on this page, with phase 1 safety trials (PMID 34346165) and phase 2 ulcer trials (PMID 23050815).

Pros
  • Full-spectrum healing with all functional domains
  • Cardioprotective Ac-SDKP domain (unique to full-length)
  • Phase 1 human clinical data
  • Anti-fibrotic: reduces scar tissue formation
Cons
  • Half-life 0.95 to 2.1 hours after IV dosing (PMID 20536472): needs daily dosing
  • More expensive than the TB-500 fragment
  • Less widely available than TB-500

Head-to-Head Comparisons

See how these ranked peptides compare side by side.

Need to calculate a dose for any peptide? Use the dosage calculator

How We Ranked These

Ranked by strength of preclinical/clinical evidence, breadth of healing applications, real-world user reports, and versatility across injury types. Peptides that address multiple healing pathways score higher.

Beginner Recommendation

Start with BPC-157 + TB-500, the gold standard healing combination. Add GHK-Cu or KPV if dealing with chronic injuries or inflammation.

View Healing & Recovery Stack →
Explore all Healing & Recovery peptides

Frequently Asked Questions

BPC-157 is the top community choice for tendon healing. In rat tendon cell studies it sped outgrowth from tendon explants and raised cell survival under stress and cell migration (PMID 21030672). That is lab work, and FDA's July 2026 briefing found no controlled human injury trial. Community protocols inject it subcutaneously near the injured tendon.

Yes. BPC-157 + TB-500 is the most popular healing stack. They target different pathways (local repair vs systemic inflammation), and users report faster recovery with the pair, though a 2026 rat study found no added benefit (PMID 42542926). The Total Recovery Stack adds GHK-Cu and KPV for maximum coverage.

Community reports most often describe improvement within 1-2 weeks. A full healing cycle usually runs 4-6 weeks. Chronic or severe injuries can need longer protocols. No trial has measured these timelines.

TB-500 is the active 7-amino-acid fragment of full-length Thymosin Beta-4 (43 amino acids). TB-500 covers actin-binding and cell migration, but the full-length protein also contains the Ac-SDKP domain responsible for cardioprotective and anti-fibrotic effects.

BPC-157 is the usual pick in community reports, often paired with TB-500 for tendon, ligament and muscle injuries. The science behind that pick comes mostly from animals. In a 2026 rat Achilles tendon study, both peptides were linked to better repair, but only TB-500 made the tendon significantly stronger (PMID 42542926). FDA's July 2026 briefing found no controlled injury trial among BPC-157's five small human studies. The only human joint data is a retrospective chart review with no control group (Lee and Padgett 2021, PMID 34324435). FDA's TB-500 briefing found no human study of TB-500 itself. The human trials people cite for it used full-length thymosin beta-4, a different molecule (PMID 34346165). This page ranks BPC-157 first for its breadth of animal data and community use. That doesn't make it the proven best in people, since no human trial has compared these peptides.
5 peptides ranked